US OptionsDetailed Quotes
ATEC250117P15000
- 0.00
- 0.000.00%
15min DelayClose Dec 27 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest15.00Strike Price0.00Turnover0.00%IV-63.22%PremiumJan 17, 2025Expiry Date5.81Intrinsic Value100Multiplier19DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma1.66Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Alphatec Stock Discussion
Sign in to post a comment
A spoonful of hot inflation makes the markets go down… That could be the song of the day, and markets are hit with a dose of reality. US producer inflation came in hotter than expected, and the Fed Chair signaled the central bank is not in any hurry to cut rates as the US economy is in “remarkably good” shape. So, ...
From YouTube
7
3
1
$Alphatec (ATEC.US)$ will it rise again?
$Roblox (RBLX.US)$ $Anavex Life Sciences (AVXL.US)$ $Santech Holdings (STEC.US)$ $Lead Real Estate (LRE.US)$ $Avadel Pharmaceuticals (AVDL.US)$ $Carvana (CVNA.US)$ $Lemonade (LMND.US)$ $Autonomix Medical (AMIX.US)$ $Peloton Interactive (PTON.US)$ $PLBY Group (PLBY.US)$ $Alphatec (ATEC.US)$ $Universal Security Instruments (UUU.US)$ $Biofrontera (BFRI.US)$ $Root Inc (ROOT.US)$
🎃⚡️🎃
🎃⚡️🎃
5
3
$Alphatec (ATEC.US)$ great solid takeoff
$Alphatec (ATEC.US)$ solid love it
$Sprouts Farmers Market (SFM.US)$ $J-Long Group (JL.US)$ $Confluent (CFLT.US)$ $Tenon Medical (TNON.US)$ $Adicet Bio (ACET.US)$ $Remitly Global (RELY.US)$ $Carvana (CVNA.US)$ $Avadel Pharmaceuticals (AVDL.US)$ $Alphatec (ATEC.US)$ $CPS Technologies (CPSH.US)$ $1847 Holdings (EFSH.US)$ $LuxUrban Hotels (LUXH.US)$ $Root Inc (ROOT.US)$
📊⚡️📊
📊⚡️📊
5
2
3
$Gelteq (GELS.US)$ $Etsy Inc (ETSY.US)$ $Orion Group (ORN.US)$ $Confluent (CFLT.US)$ $Nextracker (NXT.US)$ $Alphatec (ATEC.US)$ $Remitly Global (RELY.US)$ $Envista Holdings (NVST.US)$ $Carvana (CVNA.US)$ $1847 Holdings (EFSH.US)$ $Tenon Medical (TNON.US)$ $CPS Technologies (CPSH.US)$ $Root Inc (ROOT.US)$
📊⚡️📊
📊⚡️📊
2
$Alphatec (ATEC.US)$ Financial Outlook for the Full-Year 2024
For the fiscal year ended December 31, 2024, the Company now expects total revenue to grow 25% to $605 million compared to the previous expectation of $602 million. This includes surgical revenue of $540 million and EOS revenue of $65 million. The Company now expects non-GAAP adjusted EBITDA of approximately $27 million compared to the previous expectation of $25.5 million.
For the fiscal year ended December 31, 2024, the Company now expects total revenue to grow 25% to $605 million compared to the previous expectation of $602 million. This includes surgical revenue of $540 million and EOS revenue of $65 million. The Company now expects non-GAAP adjusted EBITDA of approximately $27 million compared to the previous expectation of $25.5 million.
$Alphatec (ATEC.US)$
director purchase $283.50k (50k shares at $5.67) as stock hits a 52 week low
use risk management.
director purchase $283.50k (50k shares at $5.67) as stock hits a 52 week low
use risk management.
1
3
No comment yet
Stock_Drift : - YouTube Seattles Best.
151740845 Stock_Drift : Ioioooooooooooooooooooioo
151453268 witso : That was a spoonful of hot analytics
